CME (CME Group) ROCE %: 16.78% (As of Mar. 2026)


CME CME Group Inc CME
81 GF Score
Price $231.58
GF Value $270.89
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is CME Group ROCE %?

CME Group CME -4.41% 81 ROCE % is 16.78% as of Mar. 2026. GuruFocus rates CME with a GF Score™ of 81/100 and a GF Value™ of $270.89 (Modestly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CME Group's annualized ROCE % for the quarter that ended in Mar. 2026 was 16.78%.

CME Group  (NAS:CME) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

CME Group ROCE % Related Terms

CME Group ROCE % Historical Data

* Premium members only.

The historical data trend for CME Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CME Group ROCE % Chart

CME Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.72 10.03 11.85 13.17 15.03

CME Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.39 14.95 13.08 17.15 16.78
CME
81GF Score
CME Group Inc CME
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CME Group ROCE % Calculation

CME Group's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=5503.9/( ( (137447 - 102313.9) + (198424.2 - 160296.7) )/ 2 )
=5503.9/( (35133.1+38127.5)/ 2 )
=5503.9/36630.3
=15.03 %

CME Group's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=6218/( ( (198424.2 - 160296.7) + (201993.5 - 165997.8) )/ 2 )
=6218/( ( 38127.5 + 35995.7 )/ 2 )
=6218/37061.6
=16.78 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 16.78% mean?
CME Group (CME) has a ROCE % of 16.78% as of Mar. 2026.
Is CME Group's ROCE % too high?
CME Group's current ROCE % is 16.78%. The Capital Markets industry median ROCE % is 5.58. CME Group's value of 16.78% is 201% above this industry median. Overall, CME Group has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CME Group's ROCE % compare to ICE and MCO?
CME Group's ROCE % of 16.78% can be compared against companies in the Capital Markets industry. The industry median ROCE % is 5.58. CME Group's value of 16.78% is 201% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Capital Markets company?
The median ROCE % among Capital Markets companies is 5.58, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CME Group's current ROCE % of 16.78% is 201% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Capital Markets industry, the median ROCE % is 5.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CME Group's current ROCE % is 16.78%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (CME) is currently considered Modestly Undervalued. The stock's GF Value™ is $270.89, compared to a current price of $231.58 — trading 14.5% below its estimated fair value. The current ROCE % is 16.78% and 201% above the Capital Markets industry median of 5.58. CME Group's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For CME Group (CME), the current ROCE % is 16.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CME Group (CME) Overvalued in 2026?

Based on GuruFocus' analysis, CME Group stock appears to be undervalued. The current stock price of $231.58 is trading 14.5% below its estimated GF Value™ of $270.89. GuruFocus considers CME Group to be Modestly Undervalued.

Key valuation signals for CME:

  • ROCE %: 16.78%
  • GF Value™: $270.89 vs. price of $231.58 (14.5% below fair value)
  • GF Score™: 81/100 with 4 warning signs
  • Industry Position: 201% above the Capital Markets median

No single metric tells the full story. See the CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CME Group Business Description

Address 20 South Wacker Drive, Chicago, IL, USA, 60606
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
81GF Score

Get the complete analysis for CME

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$231.58
Price
$270.89
GF Value